Effects of Selective Laser Trabeculoplasty

Glaucoma Clinical Trial

— SLT  

Official title:

Effect of Selective Laser Trabeculoplasty (SLT) on Diurnal Intraocular Pressure in Open-Angle Glaucoma Patients on Medical Treatment

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00986141
• Other study ID #: IRB 09-0315
• Status: Terminated
• Phase: Phase 4
• First received: September 25, 2009
• Last updated: April 23, 2013
• Start date: May 2009
• Est. completion date: December 2012

Study information

• Verified date: April 2013
• Source: University of Kentucky
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Primary objective is to evaluate the effect of selective laser trabeculoplasty (SLT) on the diurnal intraocular pressure variation in open-angle glaucoma patients (OAG).

Description:

This is a prospective observational study of OAG patients undergoing selective laser trabeculoplasty at the University of Kentucky Chandler Medical Center. The patients will be recruited over 12 months. Study will include 3 visits: pre-laser visit, visit for laser treatment and post-laser visit. All visits will occur within a 3-month period.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 30
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years to 80 Years

Eligibility

Inclusion Criteria:

• Subjects who have the diagnosis of open angle glaucoma

• Subjects who are able to speak and understand English and provide meaningful written informed consent,

• Subjects who are willing and able to comply with all testing and requirements defined in the protocol and willing and able to comply with all required study visits.

Exclusion Criteria:

• Subjects with previous laser treatment or intraocular surgery,

• Subjects with history of ocular inflammation and with history of previous ocular trauma.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Glaucoma

Intervention

Procedure:
• Surgery
Selective Laser Trabeculoplasty for glaucoma
• Selective Laser Trabeculoplasty
Glaucoma Treatment

Locations

Country	Name	City	State
United States	University of Kentucky	Lexington	Kentucky

Sponsors (1)

Lead Sponsor	Collaborator
University of Kentucky

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To evaluate the effect of selective laser trabeculoplasty on the diurnal intraocular pressure variation in OAG patients.		Three years	No